Monday, 31 August 2026European Markets

NHOA Stock Is 25% Up In The Last 5 Sessions

Loading stream...

(vianews) - shares of nhoa (cac 40: nhoa.pa) rose by a staggering 25.63% in 5 sessions from €3.2 to €4.02 at 17:06 est on tuesday, after three sequential sessions in a row of gains. cac 40 is sliding 0.12% to €7,377.52, following the last session's downward trend.

nhoa's last close was €3.89, 72.33% under its 52-week high of €14.06.

about nhoa

nhoa s.a. provides energy storage, e-mobility, and ev fastcharging infrastructure related solutions in france. the company offers solar plus storage, utility-scale storage, and industrial microgrids. it also provides charging services and devices for electric and hybrid vehicles. in addition, the company offers power house, and hybrid house; and hyess, a technology platform for the transformation of renewables into sustainable grids, as well as atlante, an estation that provides fast charging solution. nhoa s.a. is based in paris, france.

earnings per share

as for profitability, nhoa has a trailing twelve months eps of €-1.37.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -58.43%.

more news about nhoa (nhoa.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com